Table 4.
Published reports of the Xen45 and comparison with this study
| Author | Study details | Preoperative | 12 months | Bleb needling or revision (%) | ||
|---|---|---|---|---|---|---|
| IOP | Medications | IOP | Medications | |||
| Galal [6] | 13 eyes (10 with phaco) | 16 | 1.9 | 12 | 0.3 | 30.7% |
| Perez-Torregrosa [7] | 30 eyes (all with phaco) | 21.2 | 3.07 | 15.03 | 0.17 | 23.3% |
| De Gregoria [8] | 41 eyes (all with phaco) | 22.5 | 2.5 | 13.1 | 0.4 | 4.8% |
| Tan [9] | 39 eyes (no phaco) | 24.9 | 3.0 | 14.5 | 0.7 | 51.3% |
| Hengerer [10] | 148 eyes (unclear % with phaco) | 32.2 | 3.13 | 14.24 | 0.3 | 27.7% |
| Fea [11] | 12 eyes (2 with phaco) | 21.8 | 2.92 | 14.9 | 0.5 | 50% |
| Grover [12] | 65 eyes (no phaco) | 25.1 | 3.5 | 15.9 | 1.7 | 32.3% |
| This study | 68 eyes (14.7% with phaco) | 22.1 | 2.9 | 14.8 | 1.1 | 44.1% |